SHSE:600521 (China)
Â
Class A
Â¥
18.20
(+4.6%)
Nov 29
Business Description
Zhejiang Huahai Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000001DL5
Share Class Description:
SHSE:600521: Class ACompare
Compare
Traded in other countries / regions
600521.China IPO Date
2003-03-04Description
Zhejiang Huahai Pharmaceutical Co Ltd is engaged in Research & Development, production and sales of multi-dosage preparations, biological drugs, innovative drugs and specialty APIs.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.79 | |||||
| Debt-to-EBITDA | 4.03 | |||||
| Interest Coverage | 9.03 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.79 | |||||
| Beneish M-Score | -2.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.5 | |||||
| 3-Year EBITDA Growth Rate | 5 | |||||
| 3-Year EPS without NRI Growth Rate | 2.3 | |||||
| 3-Year FCF Growth Rate | 30.7 | |||||
| 3-Year Book Growth Rate | 6.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 18.19 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.73 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.74 | |||||
| 9-Day RSI | 40.53 | |||||
| 14-Day RSI | 42.75 | |||||
| 6-1 Month Momentum % | 12.46 | |||||
| 12-1 Month Momentum % | 21.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | |||||
| Quick Ratio | 0.79 | |||||
| Cash Ratio | 0.27 | |||||
| Days Inventory | 358.01 | |||||
| Days Sales Outstanding | 102.21 | |||||
| Days Payable | 152.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.15 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| 3-Year Dividend Growth Rate | 9.7 | |||||
| Forward Dividend Yield % | 1.15 | |||||
| 5-Year Yield-on-Cost % | 1.09 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | 1.14 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.13 | |||||
| Operating Margin % | 21.1 | |||||
| Net Margin % | 12.2 | |||||
| FCF Margin % | 12.53 | |||||
| ROE % | 13.55 | |||||
| ROA % | 5.93 | |||||
| ROIC % | 9.93 | |||||
| ROC (Joel Greenblatt) % | 14.69 | |||||
| ROCE % | 12.67 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.33 | |||||
| Forward PE Ratio | 19.67 | |||||
| PE Ratio without NRI | 20.18 | |||||
| Shiller PE Ratio | 36.4 | |||||
| PEG Ratio | 0.95 | |||||
| PS Ratio | 3.01 | |||||
| PB Ratio | 3.03 | |||||
| Price-to-Tangible-Book | 4.02 | |||||
| Price-to-Free-Cash-Flow | 24.11 | |||||
| Price-to-Operating-Cash-Flow | 10.66 | |||||
| EV-to-EBIT | 17.97 | |||||
| EV-to-Forward-EBIT | 19.83 | |||||
| EV-to-EBITDA | 17.97 | |||||
| EV-to-Forward-EBITDA | 18.41 | |||||
| EV-to-Revenue | 3.31 | |||||
| EV-to-Forward-Revenue | 2.93 | |||||
| EV-to-FCF | 27.06 | |||||
| Price-to-Projected-FCF | 4.36 | |||||
| Price-to-DCF (Earnings Based) | 1.75 | |||||
| Price-to-DCF (FCF Based) | 0.73 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.86 | |||||
| Price-to-Graham-Number | 1.9 | |||||
| Earnings Yield (Greenblatt) % | 5.56 | |||||
| FCF Yield % | 4.39 | |||||
| Forward Rate of Return (Yacktman) % | 10.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Huahai Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 9,348.809 | ||
| EPS (TTM) (Â¥) | 0.78 | ||
| Beta | 1.45 | ||
| Volatility % | 48.21 | ||
| 14-Day RSI | 42.75 | ||
| 14-Day ATR (Â¥) | 0.57085 | ||
| 20-Day SMA (Â¥) | 18.0695 | ||
| 12-1 Month Momentum % | 21.94 | ||
| 52-Week Range (Â¥) | 10.71 - 21.55 | ||
| Shares Outstanding (Mil) | 1,466.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Huahai Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Huahai Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Huahai Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Huahai Pharmaceutical Co Ltd(SHSE:600521)'s stock price today?
The current price of SHSE:600521 is ¥18.20. The 52 week high of SHSE:600521 is ¥21.55 and 52 week low is ¥10.71.
When is next earnings date of Zhejiang Huahai Pharmaceutical Co Ltd(SHSE:600521)?
The next earnings date of Zhejiang Huahai Pharmaceutical Co Ltd(SHSE:600521) is .
Does Zhejiang Huahai Pharmaceutical Co Ltd(SHSE:600521) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Huahai Pharmaceutical Co Ltd(SHSE:600521) is 1.15% (As of Today), Highest Dividend Payout Ratio of Zhejiang Huahai Pharmaceutical Co Ltd(SHSE:600521) was 5. The lowest was 0.13. And the median was 0.35. The  Forward Dividend Yield % of Zhejiang Huahai Pharmaceutical Co Ltd(SHSE:600521) is 1.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers